Photo Credit: SvgArtStock
Research has shown that the therapeutic potential of medicinal marijuana is more and more preferable when it comes to reducing the side effects of various treatments.
In parts of the world where medicinal properties were discovered, it has been used recreationally and medicinally for generations. Cannabis factual use for therapeutic purposes dates back approximately 5000 years, even though its derivatives were introduced in Western medicine in the nineteenth century, reaching the highest point of involvement in the 1960s.
When it comes to delineating it from the side effects such as developing a minimal psychological dependence, cannabis used as medicine is becoming more crucial.
The mood elevation of some patients using cannabis improves the quality of life by reducing nausea, vomiting and other side effects associated with various treatments, especially chemotherapy as well as radiotherapy.
Likewise, this results in the reduction of the number of prescription medicines required by some patients, with the ensuing advantage of reducing side effects culminating from medication like pain-killers, anti-rheumatic drugs, anti-depressants, and others.
Multiple studies undertaken among dispensary patients where medicinal cannabis is legal have shown that more than half of patients have replaced their prescription drugs with cannabis.
Cannabis has also been discovered to improve the component of mental health and fibromyalgia-related symptoms and chronic pain. There is evidence in some clinical studies that cannabis significantly improves general pain. However, the most significant qualitative effects were found in improving social and family relationships, in stabilizing emotional function and improving sleep.
Neurodegeneration is by far the most widespread dangers of our days; a disease characterized by a loss of neurons in certain regions of the nervous system and an inflammation that acts as a critical mechanism responsible for neurodegeneration’s progressive nature.
In fact, Alzheimer disease, Parkinson disease, and amyotrophic lateral sclerosis are among the best examples of neurodegenerative disorders associated with severe inflammation, whilst multiple sclerosis is an inflammatory disease with an early cognitive decline.
CBD which constitutes up to 40% of the Cannabis extract, is a lead compound for therapeutic development capable to exert neuroprotection and able to operate toward neuroinflammatory components of neurodegenerative diseases. But for its remarkable absence of cognitive and psychoactive actions might be the most solid candidate for clinical use, apart from its excellent profile of tolerability in humans.
While marijuana use is becoming more popular among citizens, the elderly do not seem to be an exception to it.
Conducting research involving 274 senior-class respondents, 70% confirmed that their overall health and well-being was better, their quality of life had improved and most encouragingly, they said their pain had ameliorated.
The reasons most invoked for pain relief were from lumbar and spine conditions, PTSD, headaches, glaucoma, epilepsy, depression, cancer, arthritis, anxiety, and Alzheimer’s disease.
Respondents also widely reported consuming different cannabis formulations, such as edibles, creams, smokeable buds and topical products.
In addition to that, the medical use of cannabis is increasingly focusing less on treating symptoms and diseases and more on improving patients ‘ qualitative lives. What often appears is that while not all patients are responding well to cannabis and/or cannabinoids treatment, those who do are responding very well.